By:  Benjamin Kail | bkail@masslive.com

From:  www.masslive.com

“Years ago, Somerville Mayor Joseph Curtatone believed supervised consumption sites for drug users were a bad idea.

But the 55-year-old mayor — who admitted Monday that he didn’t always handle his own brother’s and cousin’s addiction struggles with enough “humanity and decency” — now finds himself an advocate, as his city looks to host the state’s first safe consumption site and as lawmakers consider bills to decriminalize the sites, increase treatment opportunities and address a statewide epidemic of overdose deaths.”

Read More

From:  The Berkshire Eagle

BURLINGTON, Vt. — “Most of the people who come through the doors of Community Health Centers of Burlington addicted to opioids and looking for help already have tried the most effective medication the center has to offer: Suboxone.

Until recently, many were breaking the law by obtaining the drug without a prescription, taking it not to get high, but to treat their own opioid use disorder.”

Read More

Providence Journal – August 5th

Josiah “Jody” Rich is a professor of medicine and epidemiology at Brown University. Rosemarie Martin is an associate professor in the Department of Behavioral and Social Sciences at the Brown University School of Public Health. Brandon del Pozo, who served as a police officer for 23 years, contributed to this commentary. 

On July 19, The Providence Journal reported a Wyatt Detention Facility correctional officer and four others had been charged in a “suboxone smuggling scheme” involving “70 loose strips and a “brick” of 100 suboxone strips” found in a cell. The warden commended his staff “who work tirelessly to provide a safe, humane environment for the detainees, as well as protecting the public and staff.”

Such a statement suggests that presence of buprenorphine (contained in Suboxone) creates an unsafe and inhumane environment for detainees and is dangerous to the public and staff.

This is not the case. Buprenorphine saves lives in prisons and communities.

Even unprescribed buprenorphine provides life-saving treatment for opioid addiction. It is one of the most common and effective treatments for opioid use disorder (aka opioid addiction).

Read more here.

The Legislative Analysis and Public Policy Association (LAPPA), a recipient of ONDCP’s Model Acts grant, has just released a new fact sheet on fentanyl test strips.

LAPPA’s new fact sheet outlines how states can make this important harm reduction tool more accessible to their citizens. As ONDCP stated in their release this afternoon “bending the curve on the overdose epidemic requires us to meet people where they are and provide life-saving interventions, including fentanyl test strips. Read the full fact sheet here.

LAPPA concludes that “are a useful tool in the fight against overdoses and can lead to changes in an individual’s drug use as well as provide an opportunity to engage individuals in recovery, extend life-saving interventions, and offer social service supports.”

WARWICK — Anthony Perito, 39, says he was in elementary school when he started using drugs. “I was a big fan of Fred Flintstones chewables,” the multivitamin supplement for children, he said …

Read More here


www.providencejournal.com

Substance use and overdoses are an epidemic in this country, and Rhode Island is not immune. But efforts to combat substance use are often highly misunderstood. This week’s episode sheds light on some of those efforts, commonly referred to as harm reduction and overdose prevention strategies.  

Our guest expert is Dr. Brandon Marshall, a professor of epidemiology from Brown University’s School of Public Health who’s research covers substance use, infectious diseases, and the social determinants of health of urban populations.  Dr. Marshall leads the development team at the Brown University School of Public Health for Prevent Overdose RI, the statewide overdose data dashboard.

With our co-hosts Dr. Jim McDonald and Dr. Philip Chan, Dr. Marshall  directly addresses some of the common misconceptions that people have about prevention efforts like safe injection sites, needle exchange programs, and the availability of naloxone, which is a medication that can reverse the effects of a drug overdose. 

Listen to this week’s episode to learn what Rhode Island is doing to address substance use, and find out how local efforts compare to what’s going on around the globe.  

Listen Here

prisoner-health

by Kassandra Frederique, Executive Director of the Drug Policy Alliance

 

Over the past year, we have witnessed visceral examples of how the systems that purport to protect and support us too often cause harm, especially to communities of color. Yet not enough attention has been given to the central role played by the war on drugs in creating this harm, and to how ending it is integral to reimagining public safety within our communities.”

Read More

Dating violence is a serious issue on many college campuses throughout the country.

Unfortunately, substance misuse can make a troubled relationship even more volatile.

A study that surveyed 72 female college students, titled “Daily and situational reports of substance use and dating violence among college students: A 10-week prospective study,” took a closer look at this issue. In addition to physical violence, the study included “psychological aggression and sexual coercion.”

Read More

NIH-supported pilot study found team-based approach may improve buprenorphine care.

A collaborative approach to treating opioid use disorder that relies heavily on community pharmacists is feasible and may increase adherence and participant satisfaction, according to a pilot study published  in Addiction.

Most people with opioid use disorder who would benefit from medication do not receive it. Buprenorphine is a safe and effective medication that has been used in opioid addiction treatment for nearly two decades, but providers must complete training and receive a special waiver in order to prescribe buprenorphine to treat opioid use disorder. In the United States, fewer than 10% of primary care providers are authorized to prescribe buprenorphine, and more than 20 million people in the United States live in a county without a buprenorphine-waivered physician. This lack of access is a significant barrier to treatment, especially to people in underserved communities.

Read More

The Providence/Boston Center for AIDS Research Substance Use Research Core (CFAR SURC) is the only CFAR Core in the nation that focuses specifically on the intersection of substance use and HIV. The SURC is composed of 16 faculty members, who are leaders in the field of substance use and HIV research, and is led by co-Directors Christopher Kahler, PhD (Brown University) and Karsten Lunze, MD, MPH, DrPH (Boston University). 

Read More